Market Place
Sourcing Support
Biotech CEOs say they already feel impact of FDA restructure
12 Apr 2025 //
FIERCE BIOTECH
Kyowa Kirin wraps up build out of $118M biologics plant
12 Apr 2025 //
FIERCE PHARMA
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
12 Apr 2025 //
FIERCE PHARMA
Tempest, amid cash drought, hunts for liver cancer drug partner
11 Apr 2025 //
FIERCE BIOTECH
Opthea lays off 65% of staff after back-to-back phase 3 flops
11 Apr 2025 //
FIERCE BIOTECH
Vincerx`s final merger attempt collapses, leaving ADC biotech
10 Apr 2025 //
FIERCE BIOTECH
Biocon secures FDA approval for Biosimilar Bevacizumab
10 Apr 2025 //
EXPRESSPHARMA
US says $15B biotech investment is needed to dominance over China
10 Apr 2025 //
FIERCE BIOTECH
Aviceda Therapeutics Appoints Dr. Emmett, Jr. to Board
09 Apr 2025 //
BUSINESSWIRE
Amylyx Pharmaceuticals Starts Phase 1 Trial of AMX0114 in ALS
09 Apr 2025 //
BUSINESSWIRE
OS Therapies Acquires Advaxis Immuno Assets from Ayala Pharma
09 Apr 2025 //
BUSINESSWIRE
Longhorn Vaccines to Present Data on Universal Influenza Candidate
09 Apr 2025 //
BUSINESSWIRE
Worldwide Clinical Trials Adds AI for Enhanced Trials
09 Apr 2025 //
BUSINESSWIRE
Actio Biosciences Joins Piper Sandler Spring Biopharma Symposium
09 Apr 2025 //
BUSINESSWIRE
QC Kinetix Advances Regenerative Medicine with 10B Platelet Dosing
09 Apr 2025 //
BUSINESSWIRE
GSK awards $2M grant for adult vaccination, pledges $2M more by 2o25
09 Apr 2025 //
BUSINESSWIRE
Mark Cosentino, D.P.M./Ph.D., Leads City of Hope Biorepository
09 Apr 2025 //
BUSINESSWIRE
Cemvita & REMA Partner in Florianópolis for Carbon Waste Platform
09 Apr 2025 //
BUSINESSWIRE
Valneva, LimmaTech Start Ph 2 Shigella Vaccine in Infants
09 Apr 2025 //
GLOBENEWSWIRE
Augustine Therapeutics names Pascale Witz Chair of Board
09 Apr 2025 //
GLOBENEWSWIRE
FibroBiologic Expands Houston Lab for Fibroblast Based Therapeutics
08 Apr 2025 //
GLOBENEWSWIRE
Onconetix Signs Letter of Intent with Ocuvex Therapeutics
08 Apr 2025 //
GLOBENEWSWIRE
Outlook Therapeutics®: FDA Accepts ONS-5010 BLA for Wet AMD
08 Apr 2025 //
GLOBENEWSWIRE
Neurona Therapeutics Presents Positive Data from NRTX-1001 Trial
08 Apr 2025 //
GLOBENEWSWIRE
Cerevance Reports Positive Phase 1 Results for CVN293 at AAN 2025
08 Apr 2025 //
GLOBENEWSWIRE
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as CMO
08 Apr 2025 //
GLOBENEWSWIRE
Myriad Genetics Announces Inducement Awards
08 Apr 2025 //
GLOBENEWSWIRE
Serina Therapeutics Secures $5M to Advance SER-252 for Parkinson
08 Apr 2025 //
GLOBENEWSWIRE
Datroway® EU approval for metastatic HR+, HER2- breast cancer.
08 Apr 2025 //
BUSINESSWIRE
KalVista sells Japanese rights for HAE drug to Kaken
08 Apr 2025 //
BUSINESSWIRE
Rondo Therapeutics Releases Data on RNDO-564 for Bladder Cancer
08 Apr 2025 //
BUSINESSWIRE
ImmunityBio Executes $75M Equity Financing with Investor
08 Apr 2025 //
BUSINESSWIRE
Merida Biosciences Launches with $121M for Autoimmune Therapeutic
08 Apr 2025 //
BUSINESSWIRE
LifeMine Begins Phase 1 Trial of LIFE-001 for Immune Disorders
08 Apr 2025 //
BUSINESSWIRE
Atalanta Publishes Data on RNAi Therapy for KCNT1-Related Epilepsy
08 Apr 2025 //
BUSINESSWIRE
Omeros Corporation to Introduce T-CAT Program at European Congress
08 Apr 2025 //
BUSINESSWIRE
Cel-Sci Eyes Early Multikine Approval in Head, Neck Cancer
08 Apr 2025 //
BUSINESSWIRE
Terray Therapeutics Appoints Dr. Elliott Levy to Advisory Board
08 Apr 2025 //
BUSINESSWIRE
FDA approves Opdivo & Yervoy for untreated colorectal cancer
08 Apr 2025 //
BUSINESSWIRE
Roche`s Brainshuttle tech promises next-gen amyloid beta mAbs
08 Apr 2025 //
EXPRESSPHARMA
J&J showcases long-term data on nipocalimab in Myasthenia Gravis
08 Apr 2025 //
PR NEWSWIRE
Alphyn starts CLEAR-AD1 Phase 2b trial of Zabalafin Hydrogel
08 Apr 2025 //
PR NEWSWIRE
Amacathera, Pharma Partner Develop Long-Acting Biologic
08 Apr 2025 //
PR NEWSWIRE
SciTech Announces 2nd FDA Approval of a Phase 1 a/b IND For ST-001
08 Apr 2025 //
PR NEWSWIRE
Care Fertility, U-Ploid Biotech Collaborate to Improve Egg Quality
08 Apr 2025 //
PR NEWSWIRE
BioInvent gets payment as Takeda advances mezagitamab to Phase 3
08 Apr 2025 //
ACCESSWIRE
UK`s Epsilogen acquires fellow immunoglobin biotech TigaTx
08 Apr 2025 //
FIERCE BIOTECH
ABL Bio, GSK partner on Brain Delivery Platform for Diseases
08 Apr 2025 //
PR NEWSWIRE
Sumitomo Chemical sets up CRO for Oligonucleotide CDMO in US
07 Apr 2025 //
INDPHARMAPOST
Duality Bio Appoints Hua Mu as Global Chief Medical Officer
07 Apr 2025 //
PR NEWSWIRE
Gift of Life Biologics & Cellex Celebrate Successful Partnership
07 Apr 2025 //
PR NEWSWIRE
Apnimed Provides Clinical Updates for Multiple Product Candidates
07 Apr 2025 //
PR NEWSWIRE
Stramsen Biotech gets $25M funding from GEM Global Yield
07 Apr 2025 //
PR NEWSWIRE
Rise Therapeutics Reports UC Dose Escalation Results at DDW Conf
07 Apr 2025 //
PR NEWSWIRE
Neurelis to Present Seizure Treatment Analysis at AAN Meeting
07 Apr 2025 //
PR NEWSWIRE
EU Commission OKs Rybrevant with Enhanze for EGFR Lung Cancer
07 Apr 2025 //
PR NEWSWIRE
Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF
07 Apr 2025 //
ACCESSWIRE
Moderna to Present Infectious Disease Research at ESCMID 2025
07 Apr 2025 //
ACCESSWIRE
CureVac gets FDA clearance for Phase 1 trial in lung cancer
07 Apr 2025 //
ACCESSWIRE
China`s Duality Biotherapeutics tests market with $200M Hong Kong
07 Apr 2025 //
REUTERS
